# EDGAR Filing Document

**Accession Number:** 0001720580
**File Stem:** 0001720580-26-000017
**Filing Date:** 2026-3
**Character Count:** 2739
**Document Hash:** 5a59d6b9e65cb429aee039846bcc78a1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001720580-26-000017.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0001720580-26-000017

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260319

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Adicet Bio, Inc.
- **CENTRAL INDEX KEY:** 0001720580
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 813305277
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1226

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 131 DARTMOUTH STREET
- **STREET 2:** 3RD FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
- **BUSINESS PHONE:** 617-482-2333

**MAIL ADDRESS:**
- **STREET 1:** 131 DARTMOUTH STREET
- **STREET 2:** 3RD FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** resTORbio, Inc.
- **DATE OF NAME CHANGE:** 20171024

Adicet Bio, Inc.

131 Dartmouth Street, 3<sup>rd</sup> Floor

Boston, Massachusetts 02116

March 19, 2026

**<u>Via EDGAR Transmission</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Re: <u>Adicet Bio, Inc.: Registration Statement on Form S-3, filed March 12, 2026 (File No. 333-294265), as amended</u>

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "**Act**"), Adicet Bio, Inc. (the "**Company**") hereby requests that the effective date of the above-referenced registration statement, as amended (the "**Registration Statement**") be accelerated to March 23, 2026, at 4:01 p.m. Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Once the Registration Statement is effective, please orally confirm the event with Goodwin Procter LLP by calling Gabriela Morales-Rivera at (617) 570-1329. If you have any questions regarding this request, please contact Gabriela Morales-Rivera.

---

| |
|:---|
| Sincerely,<br>Adicet Bio, Inc. |
| /s/ Chen Schor |
| Chen Schor |
| President and Chief Executive Officer  |

---

cc: Nick Harvey, *Chief Financial Officer, Adicet Bio, Inc.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Danielle Lauzon, Esq., *Goodwin Procter LLP*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gabriela Morales-Rivera, Esq., *Goodwin Procter LLP*

------